LKL International BhdXKLS:0182 -14.29% ROA % is -11.07% as of Mar. 2026. The stock has 5 warning signs investors should review. Among 857 Medical Devices & Instruments companies, LKL International Bhd ranks worse than 72.23% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. LKL International Bhd's annualizedNet Income for the quarter that ended in Mar. 2026 was RM-17.32 Mil.
LKL International Bhd's average Total Assets over the quarter that ended in Mar. 2026 was RM156.50 Mil. Therefore, LKL International Bhd's annualized ROA % for the quarter that ended in Mar. 2026 was -11.07%.
The historical rank and industry rank for LKL International Bhd's ROA % or its related term are showing as below:
XKLS:0182'
s ROA % Range Over the Past 10 Years
Min: -20.32 Med: -0.3 Max: 13.14
Current: -16.97
During the past 10 years, LKL International Bhd's highest ROA % was 13.14%. The lowest was -20.32%. And the median was -0.30%.
XKLS:0182's ROA % is ranked worse than 72.23% of 857
companies
in the Medical Devices & Instruments industry
Industry Median: 0.56
vs XKLS:0182: -16.97
LKL International Bhd (XKLS:0182) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, LKL International Bhd's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LKL International Bhd ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LKL International Bhd's ROA % distribution charts can be found below:
* The bar in red indicates where LKL International Bhd's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
LKL International Bhd (XKLS:0182) has a ROA % of -11.07% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on LKL International Bhd and its competitors. According to the industry distribution chart, LKL International Bhd ranks #619 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 72.2%.
Is LKL International Bhd's ROA % too high?
LKL International Bhd's current ROA % is -11.07%. Based on the distribution chart, LKL International Bhd ranks #619 out of 857 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does LKL International Bhd's ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, LKL International Bhd ranks #619 out of 857 companies for ROA %. This places LKL International Bhd in the lower half of its industry. The industry median ROA % is 0.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.56, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on LKL International Bhd and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LKL International Bhd's current ROA % is -11.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LKL International Bhd stock overvalued right now?
Based on GuruFocus' analysis, LKL International Bhd (XKLS:0182) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.05, compared to a current price of RM0.03 — trading 40% below its estimated fair value. The current ROA % is -11.07%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For LKL International Bhd (XKLS:0182), the current ROA % is -11.07% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
LKL International Bhd is engaged in the manufacturing of medical/healthcare beds, medical peripherals and accessories as well as trading of medical furniture, medical devices, personal protective equipment, medical peripherals and accessories. The company's operating segments are Manufacturing, Trading, Retail, and Investment Holding. The Manufacturing segment is involved in the manufacturing of medical and healthcare beds, medical peripherals, and accessories, and the Trading segment is involved in the trading of medical peripherals and accessories. The company serves its products to various end users such as hospitals and medical centers, as well as other healthcare-related facilities, including clinics and specialist institutions. The majority of revenue is earned from Malaysia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0182 has been successfully added to your 